EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology

被引：11
|
作者：
Graziano, Paolo [1 ]
de Marinis, Filippo [1 ]
Gori, Bruno [1 ]
Gasbarra, Rita [1 ]
Migliorino, Rita [1 ]
De Santis, Stefano [1 ]
Pelosi, Giuseppe [2 ,3 ]
Leone, Alvaro [1 ]
机构：
[1] San Camillo Forlanini Hosp, Rome, Italy
[2] Fdn Ist Ricovero & Cura Carattere Sci, Ist Tumori, Milan, Italy
[3] Univ Milan, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
LUNG-CANCER; GEFITINIB; ERLOTINIB; PATIENT;
D O I：
10.1200/JCO.2013.49.5697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E115 / E118
页数：4
相关论文
共 50 条
  • [1] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [2] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [3] Spatiotemporal T790M Heterogeneity in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Masago, Katsuhiro
    Katakami, Nobuyuki
    Imai, Yukihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : E64 - E65
  • [4] The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancer
    Gao, Xin
    Le, Xiuning
    Costa, Daniel B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 383 - 390
  • [5] Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
    Yamane, Hiromichi
    Ochi, Nobuaki
    Yasugi, Masayuki
    Tabayashi, Takayuki
    Yamagishi, Tomoko
    Monobe, Yasumasa
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Takigawa, Nagio
    ONCOTARGETS AND THERAPY, 2013, 6 : 155 - 160
  • [6] Therapeutic approaches for T790M mutation positive non-small-cell lung cancer
    Attili, Ilaria
    Karachaliou, Niki
    Conte, PierFranco
    Bonanno, Laura
    Rosell, Rafael
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (10) : 1021 - 1030
  • [7] Detection of EGFR T790M mutation in non-small-cell lung cancer patients using colony hybridization assay
    Fujita, Yoshihiko
    Suda, Kenichi
    Kimura, Hideharu
    Matsumoto, Kazuko
    Arao, Tokuzo
    Nagai, Tomoyuki
    Hayashi, Hidetoshi
    Furuta, Kazuyuki
    Kato, Hiroaki
    Saijo, Nagahiro
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [8] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
    Imamura, Fumio
    Kimura, Madoka
    Yano, Yukihiro
    Mori, Masahide
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Ihara, Shouichi
    Komuta, Kiyoshi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Kumagai, Toru
    FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
  • [9] Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
    Kim, Insu
    Seol, Hee Yun
    Kim, Soo Han
    Kim, Mi-Hyun
    Lee, Min Ki
    Eom, Jung Seop
    CANCERS, 2023, 15 (05)
  • [10] Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer
    Kotake, M.
    Murakami, H.
    Naito, T.
    Takahashi, T.
    Kenmotsu, H.
    Ono, A.
    Wakuda, K.
    Nakashima, K.
    Omori, S.
    ANNALS OF ONCOLOGY, 2016, 27
12345